TABLE OF CONTENTS
INTRODUCTION
A Wellness-Based Healthcare System of Chronic Diseases: Prevention, Intervention, and Innovation
Robert E. Henry, Kip Piper, MA, FACHE, F. Randy Vogenberg, RPh, PhD
The 5 Eras of Healthcare Finance: Wellness as a Clinical Model
Thomas McCarter, MD, FACP; Farrah N. Daly, MD, MBA; Keri Cooper
Epidemiology and Impact of Chronic Diseases: The Promise of Prevention
Nirav R. Shah, MD, MPH
Bending the Curve, Changing Provider Organization: Implications for Wellness-Based Healthcare
Lawton Robert Burns, PhD, MBA
Wellness-Based Healthcare: Economic Incentives and Benefit Design
Gene Reeder, RPh, PhD
Wellness-Based Healthcare Policy: Medicare, Medicaid, and Private Insurance
Kip Piper, MA, FACHE
FDA Policies and Wellness-Based Healthcare: Approving and Paying for Prevention
Scott Gottlieb, MD
The Diabetes Ten City Challenge: Value-Based Benefit Design for Wellness-Based Care
Toni Fera, BPharm, PharmD
The Role of Wellness for Large Corporations: Trends and Models
Wayne M. Lednar, MD, PhD
Employers and a Culture of Health
Alberto M. Colombi, MD, MPH
Healthcare Reform: Impacts on Business
F. Randy Vogenberg, RPh, PhD
Pharmaceutical R&D Strategy and the Transition to Personalized Healthcare Planning
Michael F. Murphy, MD, PhD
The Role of Health Plans in Prevention and Wellness
Gary M. Owens, MD
Patient Engagement: From Medication Adherence to Health and Wellness
James T. Kenney, Jr, RPh, MBA
The Geisinger Model: Research Is a Core Asset
Nirav R. Shah, MD, MPH; J.B. Jones, PhD, MBA; Walter F. Stewart, PhD, MPH
CONCLUSION
Where Goes Wellness in the Scheme of Things? Acting on Prevention, Intervention, and Innovation
Robert E. Henry